Your location:Home page > Program
Search:
All Dates (UTC+8):
  • All
  • 2025-10-17 [Friday]
  • 2025-10-18 [Saturday]
  • 2025-10-19 [Sunday]
All Forums:
  • All
  • Digital Intelligence & HCC Healing Frontier – Hepatocellular Carcinoma & Liver Transplantation Summit
  • Pre-OCOT Symposium -Zhi Shu Zhong Hua
  • Forum on Liver Transplantation and Liver Cancer
  • Kidney Transplant
  • Organ Donation and Management
  • Heart/Lung/Pancreas/Intestine Transplant
  • Nursing in Transplant
All Rooms:
  • All
  • Renji Hospital
  • Grand-ballroom II
  • Grand-ballroom III
  • Pearl room
  • Yangtze River Hall

2025-10-17 (Friday)

Renji Hospital (UTC+8) 2025-10-17 Local Time

09:00-15:30 (UTC+8) 09:00-15:30 Local Time | Live Demonstration: Pediatric LDLT----Renji Hospital, Shanghai Jiao Tong University School of Medicine
Moderator:
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
09:00-15:30 09:00-15:30

All iLDLTG Council Members

15:30-17:00 (UTC+8) 15:30-17:00 Local Time | Council Meeting
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
15:30-16:30 15:30-16:30

Council Meeting

2025-10-18 (Saturday)

Grand-ballroom II (UTC+8) 2025-10-18 Local Time

08:00-08:10 (UTC+8) 08:00-08:10 Local Time | Opening Ceremony
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
08:00-08:10 08:00-08:10

Opening Ceremony and Welcome Address by Congress President and iLDLT President

08:10-08:50 (UTC+8) 08:10-08:50 Local Time | Plenary Session -Keynote lecture
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
08:10-08:30 08:10-08:30

Advancing Global Collaboration in LDLT

Kim M. Olthoff [USA]
08:30-08:50 08:30-08:50

Perspectives on Liver Transplantation: Innovation, Education, and Beyond

Zhaolong Chen [Taiwan, China]
08:50-10:25 (UTC+8) 08:50-10:25 Local Time | Session 1(A) A Global Perspective of LDLT
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
08:50-09:05 08:50-09:05

USA & North America

Elizabeth Pomfret [USA]
09:05-09:20 09:05-09:20

Europe

Jan Lerut [Belgium]
09:20-09:35 09:20-09:35

Japan

Hiroto Egawa [Japan]
09:35-09:50 09:35-09:50

South Korea

Kwang-Woong Lee [Republic of Korea]
09:50-10:05 09:50-10:05

India

Subhash Gupta [India]
10:05-10:20 10:05-10:20

China

Qiang Xia [China]
10:20-10:25 10:20-10:25

Q&A (5 min)

10:25-11:30 (UTC+8) 10:25-11:30 Local Time | Session 1(B) Technical Considerations in Minimally Invasive Donor Hepatectomy
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
10:25-10:40 10:25-10:40

Pure laparoscopic donor hepatectomy in LDLT

Kwang-Woong Lee [Republic of Korea]
10:40-10:55 10:40-10:55

Robotic-assisted donor hepatectomy in LDLT

Kamal Yadav [India]
10:55-11:10 10:55-11:10

How to establish a Robotic-assisted Donor Hepatectomy Program

Fabrizio di Benedetto [Italy]
11:10-11:25 11:10-11:25

Bile Duct Division Techniques in MIDH

Jongman Kim [Republic of Korea]
11:25-11:30 11:25-11:30

Q&A (5 min)

11:30-12:50 (UTC+8) 11:30-12:50 Local Time | Session 1(C) Transplant Oncology
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
11:30-11:45 11:30-11:45

Liver transplantation for hepatocellular carcinoma: surgical technique and innovations

Shusen Zheng [China]
11:45-12:00 11:45-12:00

Recovered Diseased Liver Transplantation

Jiahong Dong [China]
12:00-12:15 12:00-12:15

Perihilar cholangioCA and LT -- Between resection and LT

Taizo Hibi [Japan]
12:15-12:30 12:15-12:30

Improving transplantibility for locally advanced HCC: the Hong Kong approach

Albert Chi Yan Chan [Hong Kong, China]
12:30-12:45 12:30-12:45

LDLT vs DDLT in hepatobiliary oncology

Tiffany Wong [Hong Kong, China]
12:45-12:50 12:45-12:50

Q&A (5 min)

12:50-14:00 (UTC+8) 12:50-14:00 Local Time | Lunch
14:00-15:30 (UTC+8) 14:00-15:30 Local Time | Session 1(D) Technical Considerations in Recipient Surgery in LDLT
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
14:00-14:15 14:00-14:15

Pure laparoscopic LDLT Graft Implantation

Gyu-Seong Choi [Republic of Korea]
14:15-14:30 14:15-14:30

Robotic-assisted LTx in recipient

Dieter Broering [Saudi Arabia]
14:30-14:45 14:30-14:45

Complicated outflow reconstruction techniques in LDLT

Deok-Bog Moon [Republic of Korea]
14:45-15:00 14:45-15:00

Complicated portal vein reconstruction in LDLT recipients

Seisuke Sakamoto [Japan]
15:00-15:15 15:00-15:15

Complicated bile duct reconstruction in LDLT recipient

Itsuko Chih-Yi Chen [Taiwan, China]
15:15-15:25 15:15-15:25

Q&A (10 min)

15:25-15:30 15:25-15:30

Coffee Break

15:30-17:30 (UTC+8) 15:30-17:30 Local Time | Session 1(E) ILLS/iLDLTG Expert Discussion on MIDH

Meeting Format : 20 minutes for each group to present their key questions, literature analysis,and final answers (10 minutes for lecture and 10 minutes for discussion)

Beijing Time (UTC+8) Local Time Presentation Topic Speaker
15:30-15:50 15:30-15:50

Group 1: Position and Port sites

15:50-16:10 15:50-16:10

Group 2: Hilum dissection: portal vein, hepatic artery

16:10-16:30 16:10-16:30

Group 3: Parenchymal hepatic transection

16:30-16:50 16:30-16:50

Group 4: Bile duct division

16:50-17:10 16:50-17:10

Group 5: Vascular division and graft out

17:10-17:30 17:10-17:30

Group 6: Anesthesia and Pain control

Grand-ballroom III (UTC+8) 2025-10-18 Local Time

14:00-15:20 (UTC+8) 14:00-15:20 Local Time | Session 2(A) Transplant Pathology
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
14:00-14:15 14:00-14:15

Post-Liver Transplant Complications: Beyond Reiection and Recurrent Disease

Hanlin Wang [USA]
14:15-14:30 14:15-14:30

Evolving Concepts in Liver Allograft Pathology: Insights from the Banff Liver Group

Funda Yilmaz [Turkey]
14:30-14:45 14:30-14:45

Liver allograft rejection in living donor liver transplant (LDLT) recipients

Mukul Vij [India]
14:45-15:00 14:45-15:00

Transplant Pathology in Xenotransplant

Hui Guo [China]
15:00-15:10 15:00-15:10

Q&A (10 min)

15:10-15:20 15:10-15:20

Coffee break

15:20-16:50 (UTC+8) 15:20-16:50 Local Time | Session 2(B) Dealing with Marginal Donors in LT
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
15:20-15:40 15:20-15:40

Steatosis assessment and application in donor liver

DongJin Joo [Republic of Korea]
15:40-16:00 15:40-16:00

Long-term outcomes of LT recipients using Hepatitis virus-positive donor liver

James Fung [Hong Kong, China]
16:00-16:20 16:00-16:20

From Assessment to Donation: Hepatologist’s Insights on Preparing Living Liver Donors

selzner Nazia [Canada]
16:20-16:40 16:20-16:40

Strategies for expanding donor standards for split liver transplantation

Shuhong Yi [China]
16:40-16:50 16:40-16:50

Q&A (10 min)

Pearl room (UTC+8) 2025-10-18 Local Time

09:00-10:20 (UTC+8) 09:00-10:20 Local Time | Session 3(A) Advanced Technology in LT
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
09:00-09:15 09:00-09:15

Use of AI in Liver Surgery and Liver Transplantation

Jinsoo Rhu [Republic of Korea]
09:15-09:30 09:15-09:30

AI and Prediction of Outcomes in Transplantation

Daniel G Maluf [USA]
09:30-09:45 09:30-09:45

Advances in Imaging Techniques in Liver to Achieve Precision Liver Surgery

Gao Yujia [Singapore]
09:45-10:00 09:45-10:00

The prediction of hcc recurrence after liver transplantation based on radiomics

Qi Ling [China]
10:00-10:15 10:00-10:15

Integrated, intelligent and international hospital establishment for higher quality clinical medical care

Chunming Wang [China]
10:15-10:20 10:15-10:20

Q&A (5 min)

10:20-11:40 (UTC+8) 10:20-11:40 Local Time | Session 3(B) Xenotransplant
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
10:20-10:35 10:20-10:35

Auxiliary Liver Xenograft for Acute Liver Failure

Kefeng Dou [China]
10:35-10:50 10:35-10:50

Xenotransplantation- Where we are

Abraham Shaked [USA]
10:50-11:05 10:50-11:05

Clinical pig to human liver xenotransplantation: how far do we have to go?

Hongjiang Wei [China]
11:05-11:20 11:05-11:20

Xenotransplantation: current status and a perspective on the future

Leo H. Bühler [Switzerland]
11:20-11:35 11:20-11:35

Emerging technologies in chimeric humanized organs

Liangxue Lai [China]
11:35-11:40 11:35-11:40

Q&A (5 min)

11:40-12:45 (UTC+8) 11:40-12:45 Local Time | Session 3(C) Expanding the Donor Pool in LT
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
11:40-11:55 11:40-11:55

Advancing Domino Liver Transplantation: Challenges, Strategies, and Future Perspectives

Robert Minnee [Netherlands]
11:55-12:10 11:55-12:10

Pros and Cons in Dual-graft Adult Living Donor Liver Transplantation

DongHwan Jung [Republic of Korea]
12:10-12:25 12:10-12:25

New developments in liver autotransplantation

Qian Lu [China]
12:25-12:40 12:25-12:40

Waste-to-Resource Strategy in Liver Transplantation: Utilizing Discarded Partial Hepatectomy Grafts

Zhenbin Ding [China]
12:40-12:45 12:40-12:45

Q&A (5 min)

12:45-13:15 (UTC+8) 12:45-13:15 Local Time | Luncheon Symposium
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
13:15-13:45 13:15-13:45

Optimizing immunosuppression: a path to consistency, innovation, and improved outcomes

selzner Nazia [Canada]
13:15-13:45 (UTC+8) 13:15-13:45 Local Time | Luncheon Symposium
Moderator:
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
13:45-14:15 13:45-14:15

Tacrolimus in focus: Striking the optimal balance through data-driven care and personalization

YoungRok Choi [Republic of Korea]
14:00-15:30 (UTC+8) 14:00-15:30 Local Time | Session 3(D) Basic Science-Transplant Immunology
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
14:00-14:15 14:00-14:15

Liver transplantation – graft injury and cancer recurrence

Nancy Kwan Man [Hong Kong, China]
14:15-14:30 14:15-14:30

Donor Quality, Preservation, and Short-Term Outcomes in Liver Transplant: A Single-Cell and Spatial Analysis of Ischemia-Reperfusion Injury

Valeria R. Mas [USA]
14:30-14:45 14:30-14:45

EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance by targeting alloreactive CD4+ T cells

Yongbo Liu [China]
14:45-15:00 14:45-15:00

The Dual Regulatory Roles of Macrophages in Acute Allogeneic Organ Graft Rejection

Yong Zhao [China]
15:00-15:15 15:00-15:15

The role of MDSCs in tumor recurrence post LT

Hui Liu [China]
15:15-15:25 15:15-15:25

Q&A (10 min)

15:30-17:00 (UTC+8) 15:30-17:00 Local Time | Session 3(E) Oral Abstract Session (Young Investigator Award 2025)
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
15:30-15:37 15:30-15:37

Graft inflow modulation in living donor liver transplantation

Baimakhanov Bolat [Kyrgyzstan]
15:37-15:44 15:37-15:44

Impact of the High Baseline Anti-A/B Antibody titer on the clinical outcomes in ABO-incompatible Living Donor Liver Transplantation

Hyelim Joo [Republic of Korea]
15:44-15:51 15:44-15:51

SEVEN-DAY CREATININE: A CRYSTAL BALL FOR KIDNEY FATE AFTER LIVER TRANSPLANT

Viraj Panda [India]
15:51-15:58 15:51-15:58

Perioperative Management, Ethical Concerns, and Outcomes of Pediatric Domino Liver Transplants from Maple Syrup Urine Disease Donors

Vipul Gautam [India]
15:58-16:05 15:58-16:05

Evaluation Of Thrombocytopenia and Platelet Transfusion in Liver Transplant Recipients at a Quaternary Care Centre in South India

Deepti Sachan [India]
16:05-16:12 16:05-16:12

Peri-operative risk factors and outcomes in acute-on-chronic liver-failure (ACLF) patients undergoing living donor liver transplantation (LT)

Vignesh Mani [India]
16:12-16:19 16:12-16:19

Is a Functional Liver Remnant Volume Below 30% an Absolute Contraindication for Laparoscopic Living Liver Donors?

Sukmin Gwon [Republic of Korea]
16:19-16:26 16:19-16:26

The Infection Puzzle in Liver Transplantation: Risk Factors, Outcomes and Clinical Strategy

Aninditha Guraza [India]
16:26-16:33 16:26-16:33

Living Donor Liver Transplantation for Unresectable Colorectal Liver Metastasis – The University of Rochester Experience

Roberto Hernandez-Alejandro [Mexico]
16:33-16:40 16:33-16:40

Impact of Cold Ischemic Time on Rejection After Liver Transplantation: Is There a Safe Wondow?

Sehyeon Yu [Republic of Korea]
16:40-16:47 16:40-16:47

Antioxidant Therapy for Prevention of Ischemia-Reperfusion Injury in Living Donor Liver Transplantation

Sitora Gulshanova [Tajikistan]
16:47-16:54 16:47-16:54

Does GRWR Really Matters when Graft Weight is More than 650 gms in Living donor Liver Transplantation ????

hetal pampaniya [India]
16:54-17:01 16:54-17:01

Global Outcomes of Open versus Laparoscopic versus Robotic Donor Hepatectomy: A Prospective Study from the International LDLT Registry (LDLTregistry.org)

Dimitri A. Raptis [Saudi Arabia]
17:01-17:08 17:01-17:08

Renal Recovery Benefit of Living Donor Compared to Deceased Donor Liver Transplantation in High-MELD(≥35) Recipients: A Propensity Score-Matched Study

Sung-Min Kim [Republic of Korea]
17:08-17:15 17:08-17:15

Clinical heterogeneity of refractory ascites after pediatric liver transplantation modulates allograft rejection risk

Bingran Wang [China]
17:15-17:22 17:15-17:22

Mapping the Immunometabolic Landscape: Dual Axes of CCL3-Driven Macrophage Polarization and Succinate Signaling Drive Fibrosis in Pediatric Liver Transplant Recipients

Zhixin Zhang [China]
17:22-17:29 17:22-17:29

Circadian Timing of Liver Transplantation Influences the Rejection Related Injury: A Retrospective Cohort Study

Jiaqi Song [China]
17:29-17:36 17:29-17:36

Mechanism of liver circFADS2 inhibiting rejection after liver transplantation in children

Qi Pan [China]
17:36-17:43 17:36-17:43

Systematic Evaluation of Broad-PAM High-Fidelity Adenine Base Editors

Yiqing Zhang [China]
17:43-17:50 17:43-17:50

CRKP/MRSA Colonization Predicts Early Post-Liver Transplant Infection in Children: A Retrospective Matched Cohort Study

Chenling Ding [China]

Yangtze River Hall (UTC+8) 2025-10-18 Local Time

Digital Intelligence & HCC Healing Frontier – Hepatocellular Carcinoma & Liver Transplantation Summit

09:00-09:05 (UTC+8) 09:00-09:05 Local Time | Digital Intelligence & HCC Healing Frontier – Hepatocellular Carcinoma & Liver Transplantation Summit
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
09:00-09:05 09:00-09:05

Opening Remarks

09:05-10:00 (UTC+8) 09:05-10:00 Local Time | Session 1 – Digital Intelligence & Innovation
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
09:05-09:25 09:05-09:25

Roles of AI in Peri-operative Management of HCC

Alfred Kow Wei Chieh [Singapore]
09:25-09:45 09:25-09:45

AI-driven New Breakthroughs in the Precise Diagnosis and Treatment of HCC

Hong Shen [China]
09:45-10:00 09:45-10:00

Panel Discussion: Toward Precision Diagnosis and Treatment in HCC

10:00-10:55 (UTC+8) 10:00-10:55 Local Time | Session 2 – Beyond the Horizon of HCC Healing
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
10:00-10:20 10:00-10:20

A New Paradigm of Conversion Therapy for HCC in the Immunotherapy Era

Yinghong Shi [China]
10:20-10:40 10:20-10:40

The Value and Significance of TALENTACE

Zhiyuan Wu [China]
10:40-10:55 10:40-10:55

Panel Discussion: Integrated Strategies for Better Outcomes

10:55-11:00 (UTC+8) 10:55-11:00 Local Time | Closing Remarks
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
10:55-11:00 10:55-11:00

Closing Remarks

11:00-11:30 (UTC+8) 11:00-11:30 Local Time | Luncheon Symposium
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
11:00-11:30 11:00-11:30

Chinese guideline for clinical application of antithymocyte globulin in liver transplant recipients

Li Zhuang [China]

Forum on Liver Transplantation and Liver Cancer

12:00-12:10 (UTC+8) 12:00-12:10 Local Time | Forum on Liver Transplantation and Liver Cancer
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
12:00-12:15 12:00-12:15

Opening

12:10-13:25 (UTC+8) 12:10-13:25 Local Time | Section 1 Discussion on Key Technologies of Liver Transplantation
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
12:10-12:25 12:10-12:25

TBD

Guangming Li [China]
12:25-12:40 12:25-12:40

Creation and Application of New Techniques for Simultaneous Liver-Kidney Transplantation (SLKT)

Xuyong Sun [China]
12:40-12:55 12:40-12:55

Tips of Vessel Transection in Minimally Invasive Donor Hepatectomy

yi luo [China]
12:55-13:10 12:55-13:10

Discussion

13:10-13:25 13:10-13:25

Endo Lab

13:25-14:25 (UTC+8) 13:25-14:25 Local Time | Section 2 Standardized Multidisciplinary Construction of Liver Cancer
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
13:25-13:40 13:25-13:40

Standardized treatments of intrahepatic cholangiocarcinoma

Yinghong Shi [China]
13:40-13:55 13:40-13:55

Exploration of liver transplantation for liver cancer

Sheng Yan [China]
13:55-14:10 13:55-14:10

Sharing the construction experience of the AI empowered liver cancer center

Gang Chen [China]
14:10-14:25 14:10-14:25

Discussion

14:25-14:30 (UTC+8) 14:25-14:30 Local Time | Closing Remarks
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
14:25-14:30 14:25-14:30

Closing Remarks

Pre-OCOT Symposium -Zhi Shu Zhong Hua

15:00-16:20 (UTC+8) 15:00-16:20 Local Time | Session 1
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
15:00-15:10 15:00-15:10

Opening Speech

15:10-15:30 15:10-15:30

Use of Immune Induction in Split Liver Transplantation

Shuhong Yi [China]
15:30-15:50 15:30-15:50

Li Zhuang [China]
15:50-16:10 15:50-16:10

Panel discussion

16:20-17:30 (UTC+8) 16:20-17:30 Local Time | Session 2
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
16:20-16:40 16:20-16:40

Xianghui Wang [China]
16:40-17:00 16:40-17:00

Cheng Yang [China]
17:00-17:20 17:00-17:20

Panel discussion

17:20-17:40 17:20-17:40

Closing

2025-10-19 (Sunday)

Grand-ballroom II (UTC+8) 2025-10-19 Local Time

08:30-09:40 (UTC+8) 08:30-09:40 Local Time | Session 1 (F) Graft Matching in LDLT
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
08:30-08:45 08:30-08:45

LDLT Inflow Modification

James Pomposelli [USA]
08:45-09:00 08:45-09:00

How do we management SFSS in LDLT

Toru Ikegami [Japan]
09:00-09:15 09:00-09:15

Forewarning and surgical strategies for LFSS

Jiayin Yang [China]
09:15-09:30 09:15-09:30

Living-related donors for hereditary liver disease Yes or No

Ping Wan [China]
09:30-09:40 09:30-09:40

Q&A (10 min)

09:40-10:50 (UTC+8) 09:40-10:50 Local Time | Session 1(G) Paediatric LT -- Key Issues to consider
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
09:40-09:55 09:40-09:55

ABO-i LDLT in Children

Mureo Kasahara [Japan]
09:55-10:10 09:55-10:10

Hepatoblastoma and LT in Children

Hongting Huang [China]
10:10-10:25 10:10-10:25

Indication of liver transplantation for metabolic liver disease in pediatric patients

Gomathy Narasimhan [India]
10:25-10:40 10:25-10:40

Auxiliary Liver Transplantation for the Treatment of Acute Liver Failure in Children

Zhijun Zhu [China]
10:40-10:50 10:40-10:50

Q&A (10 min)

10:50-11:30 (UTC+8) 10:50-11:30 Local Time | iLDLTG GENERAL ASSEMBLY
11:30-13:00 (UTC+8) 11:30-13:00 Local Time | Luncheon Symposium
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
12:25-12:40 12:25-12:40

Subsegment-based lCG fluorescence-quided laparoscopic anatomic hepatectomy

Xiaoying Wang [China]
12:40-12:55 12:40-12:55

Comprehensive Management of Bleeding Prevention in Liver Transplantation

Zhenbin Ding [China]
13:00-14:20 (UTC+8) 13:00-14:20 Local Time | Session 1(H) Vanguard Project Presentation(10 min. presentations with 5 minutes Q&A)
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
13:00-13:05 13:00-13:05

Introduction of Vanguard Multicenter committee and ongoing projects

Yuji Soejima [Japan]
13:05-13:20 13:05-13:20

Grade 3b-complictions in LDLT-D. (Adult)

Koichiro Haruki [Japan]
13:20-13:35 13:20-13:35

SFSS Grade B (Adult)

Takeo Toshima [Japan]
13:35-13:50 13:35-13:50

LDLT using interposition graft (Pediatric)

Daniel Zamora-Valdés [Saudi Arabia]
13:50-14:05 13:50-14:05

LDLT for MMA (Pediatric)

Robert Minnee [Netherlands]
14:05-14:20 14:05-14:20

SFSS Grade A

Hye-Sung Jo [Republic of Korea]
14:25-15:55 (UTC+8) 14:25-15:55 Local Time | Session 1(I) Video demonstration
Moderator:
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
14:25-14:55 14:25-14:55

Pure Lap. Donor Right Hepatectomy

Daniel Cherqui [France]
14:55-16:25 14:55-16:25

How to lmplant Modified Right Lobe Graft having V5,V8, and Inferior Right

Sung-Min Kim [Republic of Korea]
16:25-17:55 16:25-17:55

Pure laparoscopic full-size liver transplantation in adult

Wenrui Wu [China]
15:55-16:05 (UTC+8) 15:55-16:05 Local Time | Closing Remarks

Grand-ballroom III (UTC+8) 2025-10-19 Local Time

08:30-09:40 (UTC+8) 08:30-09:40 Local Time | Session 2(E) Immunological Considerations in Liver Transplantation
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
08:30-08:45 08:30-08:45

The safety and risk of immunosuppressant withdrawn after LTx

Mark Muthiah [Singapore]
08:45-09:00 08:45-09:00

Mechanism behind immune tolerance after pediatric liver transplant

Yuan Liu [China]
09:00-09:15 09:00-09:15

Donor-derived Regulatory DC infusion in Immune Tolerance: what we know

Abhinav Humar [USA]
09:15-09:30 09:15-09:30

LT and immune suppression : another different view

Jan Lerut [Belgium]
09:30-09:45 09:30-09:45

Q&A (10 min)

09:40-10:50 (UTC+8) 09:40-10:50 Local Time | Session 2(F) Advances in Machine Perfusion in LT
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
09:40-09:55 09:40-09:55

Hypothermic machine perfusion in LTx

Robert Porte [Netherlands]
09:55-10:10 09:55-10:10

Normothermic machine perfusion in LTx

Markus Selzner [Canada]
10:10-10:25 10:10-10:25

The current status and future of ischemic-free organ transplantation

Zhiyong Guo [China]
10:25-10:40 10:25-10:40

NRP in DCD dono

Gabriel Oniscu [Sweden]
10:40-10:50 10:40-10:50

Q&A (10 min)

11:30-13:00 (UTC+8) 11:30-13:00 Local Time | Luncheon Symposium
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
11:30-12:00 11:30-12:00

围手术期胆汁淤积性肝病:早期识别与临床应对

Jun Liu [China]
11:30-12:00 11:30-12:00

Discussion

13:00-14:25 (UTC+8) 13:00-14:25 Local Time | Session 2(G) Peri-operative Considerations in Liver Transplantation
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
13:00-13:15 13:00-13:15

When to call it futile in LT?

Eleonora de Martin [France]
13:15-13:30 13:15-13:30

Clinical Management of Perioperative Infections in Liver Transplantation

Li Zhuang [China]
13:30-13:45 13:30-13:45

What is the timing of CBP after liver transplantation in critical liver failure recipients?

Huimin Yi [China]
13:45-14:00 13:45-14:00

Management of antibody mediated rejection after liver transplantation

CHUAN SHEN [China]
14:00-14:15 14:00-14:15

Diagnosis, Treatment, and Research of Severe Peri-operative Infections in Liver Transplantation

Wei Zhang [China]
14:15-14:30 14:15-14:30

Q&A (10 min)

14:25-15:55 (UTC+8) 14:25-15:55 Local Time | Session 2(H) Cell & Gene therapy -- From Bench to Bedside
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
14:25-14:45 14:25-14:45

From Lab to Clinic: Translating Bioengineered Liver Organoids for Precision Modeling and Regeneration

Yunfang Wang [China]
14:45-15:05 14:45-15:05

Progenitor Hepatocytes in Liver Disease: Therapeutic Potential and Translational Advances

Hexin Yan [China]
15:05-15:25 15:05-15:25

Precise genome editing and the translational studies

Dali Li [China]
15:25-15:45 15:25-15:45

Gene therapy to metabolic liver disease

Taihua Yang [China]
15:45-15:55 15:45-15:55

Q&A (10 min)

Pearl room (UTC+8) 2025-10-19 Local Time

Kidney Transplant

08:00-09:15 (UTC+8) 08:00-09:15 Local Time | Section 1
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
08:00-08:15 08:00-08:15

Future directions of ABO-incompatible kidney transplantation

Jiang Qiu [China]
08:15-08:30 08:15-08:30

Practice and exploration in managing recurrent kidney disease after transplantation

Qiquan Sun [China]
08:30-08:45 08:30-08:45

Interpretation of the expert consensus on donor kidney quality standards

Jiangqiao Zhou [China]
08:45-09:00 08:45-09:00

Observation of medium- and long-term outcomes of dual kidney transplantation in adults

Weijie Zhang [China]
09:00-09:15 09:00-09:15

Discussant

09:15-10:30 (UTC+8) 09:15-10:30 Local Time | Section 2
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
09:15-09:30 09:15-09:30

Exploration and practice in xenotransplantation

Gang Chen [China]
09:30-09:45 09:30-09:45

Advances in antibody research and application in kidney transplantation

Gang Huang [China]
09:45-10:00 09:45-10:00

Establishment of kidney organoid platforms and prospects for large-scale application

ruiming rong [China]
10:00-10:15 10:00-10:15

Multitarget therapy for antibody-mediated rejection after kidney transplantation

Jin Zheng [China]
10:15-10:30 10:15-10:30

Discussant

10:30-10:45 10:30-10:45

Coffee break

10:45-11:45 (UTC+8) 10:45-11:45 Local Time | Section 3
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
10:45-11:00 10:45-11:00

Multitarget therapy for antibody-mediated rejection after kidney transplantation

Ming Zhang [China]
11:00-11:15 11:00-11:15

Practice of pediatric kidney transplantation

Changxi Wang [China]
11:15-11:30 11:15-11:30

nduction management in living kidney transplantation

Xubiao Xie [China]
11:30-11:45 11:30-11:45

Discussant

11:45-12:45 (UTC+8) 11:45-12:45 Local Time | Session 4
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
11:45-12:00 11:45-12:00

Use of mineralocorticoid receptor antagonists in kidney transplantation

Jun Lin [China]
12:00-12:15 12:00-12:15

2025 ATC: International Hot Topics and New Advances in ABMR Prevention and Treatment in Kidney Transplantation

Xianghui Wang [China]
12:15-12:30 12:15-12:30

Differentiation after Syndrome Differentiation: De Novo Malignancies After Transplantation

Yun Miao [China]
12:30-12:45 12:30-12:45

Discussant

12:45-14:00 (UTC+8) 12:45-14:00 Local Time | Luncheon Symposium
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
12:45-13:15 12:45-13:15

Advances in clinical application of mTOR inhibitors in organ transplantation

Xianghui Wang [China]

Organ Donation and Management

14:10-15:25 (UTC+8) 14:10-15:25 Local Time | Session 1
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
14:10-14:25 14:10-14:25

Several Issues in Organ Donation after Brain Death/Circulatory Death Determination

Ying Cheng [China]
14:25-14:40 14:25-14:40

Assessment and application of ECD Kidney

Chenguang Ding [China]
14:40-14:55 14:40-14:55

Experience Sharing on OPO Donation Practices in Jiangsu Province

Guoyang Shao [China]
14:55-15:10 14:55-15:10

Technological Innovation, Institutional Reconstruction and Governance of Global Donation and Transplantation from Multiple Perspectives

Wenshi Jiang [China]
15:10-15:25 15:10-15:25

Discussant

15:25-16:50 (UTC+8) 15:25-16:50 Local Time | Session 2
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
15:25-15:40 15:25-15:40

Normothermic Regional Machine Perfusion

Zhiyong Guo [China]
15:40-15:55 15:40-15:55

Advances in Research on Renal Function Protection in Kidney Transplantation

Yanfeng Wang [China]
15:55-16:10 15:55-16:10

How to Do a Good Job in Organ Donation from the Perspective of the Intensive Care Unit

Hui Zhang [China]
16:10-16:25 16:10-16:25

Experience in Pediatric Organ Donation

Wei Jia [China]
16:25-16:40 16:25-16:40

Discussion

16:50-18:05 (UTC+8) 16:50-18:05 Local Time | Session 3
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
16:50-17:05 16:50-17:05

Maintenance and management of potential donors

Chuanshen Xu [China]
17:05-17:20 17:05-17:20

TBD

Gongtao Qian [China]
17:20-17:35 17:20-17:35

Common Legal and Ethical Issues of Organ Donation and Transplantation

Ziqin Yao [China]
17:35-17:50 17:35-17:50

Enhancing Donation via Emergency and Critical Care

Xiaogang Gao [China]
17:50-18:05 17:50-18:05

Discussion

Yangtze River Hall (UTC+8) 2025-10-19 Local Time

Heart/Lung/Pancreas/Intestine Transplant

08:00-09:30 (UTC+8) 08:00-09:30 Local Time | One. Islet and Regenerative Islet Transplantation
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
08:00-08:30 08:00-08:30

“Beyond Immunosuppression: Next-Generation Cell Therapies for T1DM(40 years anniversary of the invention of the Ricordi Chamber and Automated method)”

Camillo Ricordi [USA]
08:30-08:50 08:30-08:50

Advances in the Diagnosis and Treatment of Type 1 Diabetes

Linong Ji [China]
08:50-09:10 08:50-09:10

In Vitro Reconstruction and Application of Islet Tissue

Xin Cheng [China]
09:10-09:30 09:10-09:30

Islet Transplantation Experience at Changzheng Hospital (2016–2025)

Meng Guo [China]
09:30-09:45 09:30-09:45

Discussant

09:45-10:05 (UTC+8) 09:45-10:05 Local Time | Two. Heart, Lung, Pancreas, and Small Intestine Transplantation
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
09:45-10:05 09:45-10:05

Clinical Report on Pediatric Heart Transplantation

Zhongqun Zhu [China]
10:05-10:25 10:05-10:25

Technical Optimization of Lung Transplantation for Pulmonary Fibrosis

chang chen [China]
10:25-10:45 10:25-10:45

Exploration and Considerations of Arterial and Venous Shunting Techniques in Donor Pancreas and Spleen

Jiali Fang [China]
10:45-11:05 10:45-11:05

Small Intestine Transplantation for Intestinal

Chaoxu Liu [China]
11:05-11:25 11:05-11:25

Discussant

11:25-13:00 (UTC+8) 11:25-13:00 Local Time | Three. Islet Transplantation + Regenerative/Xenogeneic Islets
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
11:25-11:45 11:25-11:45

Efforts in Disruptive Technology Innovation

An Jin [China]
11:45-12:05 11:45-12:05

SLC Based Metabolic Pharmacology

Ligong Chen [China]
12:05-12:25 12:05-12:25

Study on the Regulation of Macrophage Function by Cholesterol Metabolism

红艳 王 [China]
12:25-12:45 12:25-12:45

Research and Development of Candidate Drugs Targeting ACLY for Hyperlipidemia and Metabolic-Associated Fatty Liver Disease

jingya li [China]
12:45-13:05 12:45-13:05

Discussant

Nursing in Transplant

14:00-14:10 (UTC+8) 14:00-14:10 Local Time | Theme: Focus · Empower · Integrate — Building a New Model of High-Quality Transplant Nursing
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
14:00-14:05 14:00-14:05

Address

14:05-14:10 14:05-14:10

Group photo

14:10-15:50 (UTC+8) 14:10-15:50 Local Time | Exploring Cutting-Edge Nursing Models, Empowering the Development of Transplant Nursing
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
14:10-14:30 14:10-14:30

"Development and Prospects of the Nursing Discipline at Shanghai Jiao Tong University School of Nursing" Nursing College, Shanghai Jiao Tong University

Qiong Fang [China]
14:30-14:50 14:30-14:50

"Organ Donation and Allocation: Defending the Family-First Principle in China" Center for Health Reform and Development Studies, Xi’an Jiaotong University School of Public Health

Mingxu Wang [China]
14:50-15:10 14:50-15:10

"Evidence-Based Clinical Practice of Exercise Rehabilitation for Kidney Transplant Recipients" The Third Xiangya Hospital of Central South University

Jia Liu [China]
15:10-15:30 15:10-15:30

"Development and Continuous Improvement Strategies of Transplant Nursing Quality Standards" The First Affiliated Hospital of Xi’an Jiaotong University

Dan Li [China]
15:30-15:50 15:30-15:50

Discussant

15:40-15:50 15:40-15:50

Coffee break

15:50-17:20 (UTC+8) 15:50-17:20 Local Time | Enhancing Professional Competence and Quality Control, Leading the Development of Specialized Transplant Nursing
Beijing Time (UTC+8) Local Time Presentation Topic Speaker
15:50-16:10 15:50-16:10

"Development and Practice of the Core Competency Training System for Transplant Specialist Nurses" Medical Application Technology College, Guangdong Lingnan Institute of Technology

Guirong Ye [China]
16:10-16:30 16:10-16:30

"Postoperative Rehabilitation Management of Critically Ill Transplant Patients" Renji Hospital, Shanghai Jiao Tong University School of Medicine

Zhen Chen [China]
16:30-16:50 16:30-16:50

"Case Management Practice for Hepatobiliary and Pancreatic Tumors" Beijing Tsinghua Changgung Hospital, Affiliated to Tsinghua University

zhe Yan [China]
16:50-17:10 16:50-17:10

"Experience Sharing from Transplant Specialist Nurses in Singapore" Singapore General Hospital

Chua Siew Huang [Singapore]
17:10-17:20 17:10-17:20

Discussant